Algeria Joins European Bank for Reconstruction and Development

Algeria Joins European Bank for Reconstruction and Development
TT

Algeria Joins European Bank for Reconstruction and Development

Algeria Joins European Bank for Reconstruction and Development

The European Bank for Reconstruction and Development has approved a request by Algeria to become a member of the multilateral financial institution, the Bank announced on Tuesday.

The membership opens the way for Algeria to potentially receive funding to support private sector competitiveness, promote sustainable supplies of energy and enhance the quality and efficiency of public services in the country.

“Our goal will be to unleash the potential of Algeria, particularly in the private sector, to create jobs and support sustainable development,” said EBRD’s Acting President Jurgen Rigterink.

“Similar to our support to Algeria’s neighboring countries, the EBRD can mobilize significant financial resources as well as technical expertise and advisory services.”

The EBRD was set up in 1991 to help ex-communist countries of Eastern Europe shift to market economies.

Majority owned by G7 top economic powers, it has widened its geographic scope in recent years to include Egypt, Tunisia and Morocco in Africa.

The Bank has invested over 12 billion euros in 260 projects across the southern and eastern Mediterranean region in natural resources, financial institutions, agribusiness, manufacturing and services, as well as infrastructure projects such as power, municipal water and wastewater, and transport services.

EBRD’s interest in investing in Algeria comes in light of the government’s announcement on Monday of its aim to save $20 billion this year through reforms and by lowering its imports bill.

The OPEC member has been under pressure to ease the impact of a drop in oil and gas earnings on its public finances.

It already cut public spending and postponed planned investment projects for 2020 in several sectors, including energy, which accounts for 60 percent of the state budget and 93 percent of total export revenues.

Failure to implement reforms aimed at diversifying the economy away from oil and gas means the North African country’s non-energy sector is still underdeveloped.

The government said in a statement that a cabinet meeting chaired by President Abdelmadjid Tebboune discussed the need for urgent steps to reform the banking system and attract money from the informal market.

Ministers also discussed reducing the cost of imports through measures including using the national fleet to ship imported goods.

Algeria spends an estimated $45 billion annually on imports of goods including food because domestic output is insufficient to meet growing demand from the country’s 44 million people.

The meeting also discussed speeding up a long-delayed plan to launch an Islamic finance sector to provide a new funding source for the economy.

The government hopes Sharia-compliant financial services would attract local savers who distrust state banks and often opt to keep large sums of money at home.

“All these measures would enable Algeria to save about $20 billion before the end of this year,” the statement quoted Tebboune as saying at the meeting.

It described the steps discussed as part of a government “economic and social revival plan,” aimed at reducing reliance on the energy sector and opening up the economy to investors who have stayed away due to bureaucracy and a lack of incentives.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.